Bain Capital Public Equity Management II’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bain Capital Public Equity Management II’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-237,503	Closed	-$3.92M	–	74
2021 Q1	$3.92M	Sell	237,503 -389,884	-62%	-$8.88M	0.16%	49
2020 Q4	$11.6M	Buy	627,387 +389,884	+164%	+$6.98M	0.59%	31
2020 Q3	$3.23M	Hold	237,503	–	–	0.21%	34
2020 Q2	$4.26M	Sell	237,503 -179,167	-43%	-$2.7M	0.33%	33
2020 Q1	$4.15M	Hold	416,670	–	–	0.49%	28
2019 Q4	$3.39M	Hold	416,670	–	–	0.32%	30
2019 Q3	$4.13M	Hold	416,670	–	–	0.39%	37
2019 Q2	$5.26M	Buy	+416,670	New	+$4.39M	0.49%	34

Other funds holding TBIO

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AVA

Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bain Capital Public Equity Management II's TBIO Position: Q2 2021 in Review

Bain Capital Public Equity Management II sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2021, closing a stake of 237,503 shares — an estimated $3.92M sold.

Bain Capital Public Equity Management II first reported a position in TBIO in Q2 2019 and held it in 8 quarters. The position peaked at $11.6M in Q4 2020. 145 funds tracked by Wall St. Rank hold TBIO as of Q2 2021.

Bain Capital Public Equity Management II reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Bain Capital Public Equity Management II sold 237,503 Translate Bio, Inc. Common Stock shares in Q2 2021, an estimated $3.92M.
Bain Capital Public Equity Management II first reported a position in Translate Bio, Inc. Common Stock in Q2 2019 and held it in 8 quarters.
Bain Capital Public Equity Management II's Translate Bio, Inc. Common Stock position peaked at $11.6M in Q4 2020.
145 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2021.

Based on Bain Capital Public Equity Management II's 13F filing for Q2 2021, filed 16 Aug 2021.